Full article view2018-09-26T10:16:49+00:00

Molecular Medicine Tri-Con 2017

February 20-24, 2017

San Francisco, CA

Booth #201

Precision for Medicine will be exhibiting at Molecular Medicine Tri-Con 2017 from February 20-24, at the Moscone North Convention Center in San Francisco, CA.

Schedule of Events:

Poster hours: posters will be presented during all the main conference exhibit hall breaks.

  • Monday, February 20
    6:00pm – 7:30pm     Grand Opening Reception
  • Tuesday, February 21
    9:00- 10:05am         Refreshment Break – Dedicated Viewing
    1:25-2:00pm          Refreshment Break – Dedicated Viewing
    4:10-5:00pm          Hollywood Oscar’s Dessert Break – Dedicated Viewing
  • Wednesday, February 22
    10:00-10:50am      Refreshment Break – Dedicated Viewing
    1:10-1:50pm          Refreshment Break – Dedicated Viewing

 

Scott Marshall

  • Poster #73: Leveraging a Series of Studies to Optimize Success in CDx Development
  • Poster #74: A Harmonized Approach to Biomarker Data Management – Innovative Informatics to Improve Efficiency, Quality and Delivery of Specialty Lab Data in Support of Clinical Trials

David Parker

  • Poster #75: Issues Affecting Market Access, Adoption, and Impact of a Companion/Complementary Diagnostic Test in the Community Care Setting

Deborah Phippard

  • Poster #76: Precision in the Detection of Myeloid-Derived Suppressor Cells (MDSCs)

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

What kind of expertise do you need?





By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK